Mobile Application-Based Seoul National University Prostate Cancer Risk Calculator: Development, Validation, and Comparative Analysis with Two Western Risk Calculators in Korean Men | PLOS ONE
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1a.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
![Improved predictive performance of prostate biopsy collaborative group risk calculator when based on automated machine learning - ScienceDirect Improved predictive performance of prostate biopsy collaborative group risk calculator when based on automated machine learning - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0010482521006971-mmcfigs4.jpg)
Improved predictive performance of prostate biopsy collaborative group risk calculator when based on automated machine learning - ScienceDirect
![IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies](https://www.mdpi.com/ijms/ijms-24-02449/article_deploy/html/images/ijms-24-02449-g001.png)
IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov-2-FI.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/3-Figure1-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
![Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | World Journal of Urology Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | World Journal of Urology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-017-2150-1/MediaObjects/345_2017_2150_Fig2_HTML.gif)
Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | World Journal of Urology
![External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - ScienceDirect External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S240545692200284X-gr2.jpg)
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - ScienceDirect
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/5-Figure2-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
![A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-019-0553-6/MediaObjects/12894_2019_553_Fig2_HTML.png)
A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text
![IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis](https://www.mdpi.com/ijms/ijms-20-01637/article_deploy/html/images/ijms-20-01637-g001-550.jpg)
IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
![Frontiers | Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? Frontiers | Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?](https://www.frontiersin.org/files/Articles/603384/fonc-10-603384-HTML-r1/image_m/fonc-10-603384-g001.jpg)
Frontiers | Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283812008342-gr2.jpg)